Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 49.07% vs 36.89% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -1.38% vs -15.03% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 86.58% vs 54.94% in Mar 2025
Compare Balance Sheet Results of Parmax Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.45
13.18
-8.73
-66.24%
Share Warrants & Outstandings
Total Reserve
-10.60
33.50
-44.10
-131.64%
Shareholder's Funds
-6.15
48.51
-54.66
-112.68%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
12.06
1.81
10.25
566.30%
Secured Loans
7.93
1.81
6.12
338.12%
Unsecured Loans
4.13
0.00
4.13
0.00%
Deferred Tax Assets / Liabilities
-1.88
0.64
-2.52
-393.75%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.16
-0.16
-100.00%
Long Term Provisions
0.00
2.72
-2.72
-100.00%
Total Non-Current Liabilities
9.64
5.32
4.32
81.20%
Current Liabilities
Trade Payables
14.34
6.02
8.32
138.21%
Other Current Liabilities
7.33
1.78
5.55
311.80%
Short Term Borrowings
0.54
9.80
-9.26
-94.49%
Short Term Provisions
0.47
0.41
0.06
14.63%
Total Current Liabilities
22.68
18.02
4.66
25.86%
Total Liabilities
26.17
71.85
-45.68
-63.58%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
18.59
39.98
-21.39
-53.50%
Less: Accumulated Depreciation
10.73
29.07
-18.34
-63.09%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
7.86
10.91
-3.05
-27.96%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
2.43
-2.43
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.40
2.25
-1.85
-82.22%
Long Term Loans & Advances
1.23
0.08
1.15
1,437.50%
Other Non Current Assets
0.00
6.71
-6.71
-100.00%
Total Non-Current Assets
9.49
22.38
-12.89
-57.60%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
7.85
18.35
-10.50
-57.22%
Sundry Debtors
3.16
28.13
-24.97
-88.77%
Cash and Bank
0.65
0.74
-0.09
-12.16%
Other Current Assets
0.00
1.12
-1.12
-100.00%
Short Term Loans and Advances
5.02
1.14
3.88
340.35%
Total Current Assets
16.68
49.47
-32.79
-66.28%
Net Current Assets (Including Current Investments)
-6.00
31.45
-37.45
-119.08%
Total Current Assets Excluding Current Investments
16.68
49.47
-32.79
-66.28%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
26.17
71.85
-45.68
-63.58%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
11.52
11.61
-0.09
-0.78%
Book Value per share (adjusted)
-13.81
35.43
-49.24
-138.98%
Annual - Borrowings
Borrowings 12.06 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 49.07% vs 36.89% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 7.86 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -1.38% vs -15.03% in Mar 2025
Annual - Investments
Investments 0.40 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 16.68 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 86.58% vs 54.94% in Mar 2025